These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma. Trubicka J; Szperl M; Grajkowska W; Karkucińska-Więckowska A; Tarasińska M; Falana K; Dembowska-Bagińska B; Łastowska M Folia Neuropathol; 2016; 54(1):23-30. PubMed ID: 27179218 [TBL] [Abstract][Full Text] [Related]
8. [Reliability of molecular tumour markers in children with medulloblastoma--an example from clinical practice]. Pfister S Z Evid Fortbild Qual Gesundhwes; 2011; 105(7):511-3. PubMed ID: 21958611 [TBL] [Abstract][Full Text] [Related]
9. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma. Wang C; Yun Z; Zhao T; Liu X; Ma X Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036 [TBL] [Abstract][Full Text] [Related]
10. Molecular progression of SHH-activated medulloblastomas. Korshunov A; Okonechnikov K; Sahm F; Ryzhova M; Stichel D; Sievers P; Meyer J; Schrimpf D; Zheludkova O; Golanov A; Lichter P; Jones DTW; Pfister SM; von Deimling A; Kool M Acta Neuropathol; 2019 Aug; 138(2):327-330. PubMed ID: 31030238 [No Abstract] [Full Text] [Related]
11. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256 [TBL] [Abstract][Full Text] [Related]
12. Desmoplastic medulloblastoma: MR findings. Levy RA; Blaivas M; Muraszko K; Robertson PL AJNR Am J Neuroradiol; 1997 Aug; 18(7):1364-6. PubMed ID: 9282870 [TBL] [Abstract][Full Text] [Related]
13. Histological subtype of medulloblastoma frequently changes upon recurrence. Pöschl J; Koch A; Schüller U Acta Neuropathol; 2015 Mar; 129(3):459-61. PubMed ID: 25662941 [No Abstract] [Full Text] [Related]
14. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples. D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195 [TBL] [Abstract][Full Text] [Related]
16. Meningeal signs as the presenting feature of medulloblastoma. Pollono DG; Tomarchio S; Drut R; Jones M; Ripoli MC; Fortuni ME Med Pediatr Oncol; 1999 Jun; 32(6):477-8. PubMed ID: 10358718 [No Abstract] [Full Text] [Related]
17. Redefining the molecular substructure of medulloblastoma. Benmaamar R Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377 [No Abstract] [Full Text] [Related]
18. Cerebellar medulloblastoma in the adult. Clinico-pathological correlation. Roscher AA; Loffman M; Endlich HL Int Surg; 1973 Aug; 58(8):561-4. PubMed ID: 4728999 [No Abstract] [Full Text] [Related]
19. [Histological diagnosis of brain tumors: (19). Medulloblastoma]. Nagashima K No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431 [No Abstract] [Full Text] [Related]
20. Somatic Versus Germline: A Case Series of Three Children With Tam LT; Cole B; Stasi SM; Paulson VA; Wright JN; Hoeppner C; Holtzclaw S; Crotty EE; Ellenbogen RG; Lee A; Ermoian RP; Lockwood CM; Leary SES; Ronsley R JCO Precis Oncol; 2024 Jan; 8():e2300333. PubMed ID: 38207225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]